{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:40:00Z","timestamp":1770493200180,"version":"3.49.0"},"reference-count":25,"publisher":"Sociedade Brasileira de Cardiologia","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,19]]},"DOI":"10.36660\/abc.20190656","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T20:38:01Z","timestamp":1614371881000},"page":"238-247","source":"Crossref","is-referenced-by-count":5,"title":["Desfechos em Pacientes com Fen\u00f4meno de No-Reflow Coron\u00e1rio e a Rela\u00e7\u00e3o entre a Mol\u00e9cula-1 de Les\u00e3o Renal e o Fen\u00f4meno de No-Reflow Coron\u00e1rio"],"prefix":"10.36660","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8740-1429","authenticated-orcid":false,"given":"Mustafa Ahmet","family":"Huyut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin Hatice","family":"Yamac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"5","key":"key20210226153759_B1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon","volume":"105","author":"Rezkalla","year":"2002","unstructured":". Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002 Feb 5;105(5):656-62.","journal-title":"Circulation"},{"issue":"4","key":"key20210226153759_B2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MCA.0000000000000726","article-title":"Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"30","author":"Tasar","year":"2019","unstructured":". Tasar O, Karabay AK, Oduncu V, Kirma C. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis. 2019 Jun;30(4):270-6.","journal-title":"Coron Artery Dis"},{"key":"key20210226153759_B3","article-title":"CHA2DS2VASc Score and Coronary No-Reflow Phenomenon","author":"Yarlioglues","year":"2019","unstructured":". Yarlioglues M, Yalcinkaya D, Celik IE, Duran M. CHA2DS2VASc Score and Coronary No-Reflow Phenomenon. Angiology. 2019 May 23:3319719851698. doi: 10.1177\/0003319719851698.","journal-title":"Angiology"},{"issue":"2","key":"key20210226153759_B4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.2175","article-title":"Tubular kidney injury molecule-1 (KIM-1) in human renal disease","volume":"212","author":"van Timmeren","year":"2007","unstructured":". van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007 Jun;212(2):209-17.","journal-title":"J Pathol"},{"issue":"13","key":"key20210226153759_B5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","unstructured":". Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 Sep 23;351(13):1296-305. Erratum in: N Engl J Med. 2008;18(4):4.","journal-title":"N Engl J Med"},{"issue":"5","key":"key20210226153759_B6","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0492-2","article-title":"Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: A population-based cohort study","volume":"18","author":"Gammelager","year":"2014","unstructured":". Gammelager H, Christiansen CF, Johansen MB, T\u00f8nnesen E, Jespersen B, S\u00f8rensen HT. Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: A population-based cohort study. Crit Care. 2014 Oct 14;18(5):492.","journal-title":"Crit Care"},{"issue":"2","key":"key20210226153759_B7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","unstructured":". Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H,  et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"7","key":"key20210226153759_B8","first-page":"503","article-title":"JNC 8 Guidelines for the Management of Hypertension in Adults","volume":"90","author":"Armstrong","year":"2014","unstructured":". Armstrong C, Joint National Committee. JNC 8 Guidelines for the Management of Hypertension in Adults, Am Fam Physician 2014 Oct 1;90(7):503-4.","journal-title":"Am Fam Physician"},{"key":"key20210226153759_B9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.11.3160","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","unstructured":". Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1): S5-20.","journal-title":"Diabetes Care"},{"key":"key20210226153759_B10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","unstructured":". National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report. Circulation. 2002;106:3143-421.","journal-title":"Circulation"},{"issue":"5","key":"key20210226153759_B11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","unstructured":". Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ,  et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996 Mar 1;93(5):879-88.","journal-title":"Circulation"},{"key":"key20210226153759_B12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2015.03.359","article-title":"Novel insights into an \u201cold\u201d phenomenon: the no reflow","volume":"187","author":"Durante","year":"2015","unstructured":". Durante A, Camici PG. Novel insights into an \u201cold\u201d phenomenon: the no reflow. Int J Cardiol. 2015;187:273-80.","journal-title":"Int J Cardiol"},{"issue":"21","key":"key20210226153759_B13","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"55","author":"Ndrepepa","year":"2010","unstructured":". Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA,  et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010 May 25;55(21):2383-9.","journal-title":"J Am Coll Cardiol"},{"key":"key20210226153759_B14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/oby.2006.277","article-title":"Why visceral fat is bad: mechanisms of the metabolic syndrome","volume":"14","author":"Bergman","year":"2006","unstructured":". Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M,  et al. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring). 2006 Feb;14(suppl 1):16-19.","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"key20210226153759_B15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1076029614558113","article-title":"Increased epicardial adipose tissue thickness is associated with angiographic thrombus burden in the patients with non-st-segment elevation myocardial infarction","volume":"21","author":"Bakirci","year":"2015","unstructured":". Bakirci EM, Degirmenci H, Duman H, Inci S, Hamur H, Buyuklu M,  et al. Increased epicardial adipose tissue thickness is associated with angiographic thrombus burden in the patients with non-st-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2015 Oct;21(7):612-8.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"key20210226153759_B16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0003319715622844","article-title":"CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention","volume":"67","author":"Ipek","year":"2016","unstructured":". Ipek G, Onuk T, Karatas MB, Gungor B, Osken A, Keskin M,  et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016 Oct;67(9):840-5.","journal-title":"Angiology"},{"issue":"9628","key":"key20210226153759_B17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(08)60833-8","article-title":"Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study","volume":"371","author":"Vlaar","year":"2008","unstructured":". Vlaar PJ, Svilaas T, van der Horst IWC, Diercks GFH, Fokkema ML, de Smet BJGL, et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008 Jun 7;371(9628):1915-20.","journal-title":"Lancet"},{"issue":"1","key":"key20210226153759_B18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjcard.2004.03.026","article-title":"Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function","volume":"94","author":"Danzi","year":"2004","unstructured":". Danzi G, Sesana M, Capuano C, Mauri L, Centurini PB, Baglini R. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. Am J Cardiol. 2004 Jul 1;94(1):35-9.","journal-title":"Am J Cardiol"},{"issue":"5","key":"key20210226153759_B19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0735-1097(01)01138-X","article-title":"Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience","volume":"37","author":"Hillegass","year":"2001","unstructured":". Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol. 2001 Apr;37(5):1335-43.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20210226153759_B20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.05.010","article-title":"Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial","volume":"152","author":"Amit","year":"2006","unstructured":". Amit G, Cafri C, Yaroslavtsev S, Fuchs S, Paltiel O, Abu-Ful A,  et al. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 2006 Nov;152(5):887. e9-14.","journal-title":"Am Heart J"},{"key":"key20210226153759_B21","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-015-0004-6","article-title":"Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study","volume":"15","author":"Aksu","year":"2015","unstructured":". Aksu T, Guler TE, Colak A, Baysal E, Durukan M, Sen T,  et al. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2015 Feb 19;15:10.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"key20210226153759_B22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ccd.10303","article-title":"Resolution of refractory no-reflow with intracoronary epinephrine","volume":"57","author":"Skelding","year":"2002","unstructured":". Skelding KA, Goldstein JA, Mehta L, Pica MC, O\u2019Neill WW. Resolution of refractory no-reflow with intracoronary epinephrine. Catheter Cardiovasc Interv. 2002 Nov;57(3):305-9.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"key20210226153759_B23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.amjcard.2013.03.032","article-title":"EuroSCORE II versus additive and logistic EuroSCORE in patients undergoing percutaneous coronary intervention","volume":"112","author":"Capodanno","year":"2013","unstructured":". Capodanno D, Dipasqua F, Marcantoni C, Ministeri M, Zanoli L, Rastelli S,  et al. EuroSCORE II versus additive and logistic EuroSCORE in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2013 Aug 1;112(3):323-9.","journal-title":"Am J Cardiol"},{"issue":"2","key":"key20210226153759_B24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5578\/khj.10925","article-title":"Importance of EuroSCORE-II in the Development of Acute Ischemic Heart Failure After Acute Anterior ST Elevation Myocardial Infarction","volume":"19","author":"Gul","year":"2016","unstructured":". Gul I, Zungur M, Aykan A, Islamli A, Yildiz B, Bilgin M. Importance of EuroSCORE-II in the Development of Acute Ischemic Heart Failure After Acute Anterior ST Elevation Myocardial Infarction. Ko\u015fuyolu Heart Journal. 2016; 19(2): 71-65.","journal-title":"Ko\u015fuyolu Heart Journal"},{"issue":"3","key":"key20210226153759_B25","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","article-title":"Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury","volume":"286","author":"Ichimura","year":"2004","unstructured":". Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004 Mar;286(3):F552-63.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/abccardiol.org\/article\/desfechos-em-pacientes-com-fenomeno-de-no-reflow-coronario-e-a-relacao-entre-a-molecula-1-de-lesao-renal-e-o-fenomeno-de-no-reflow-coronario\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:03:44Z","timestamp":1747400624000},"score":1,"resource":{"primary":{"URL":"http:\/\/abccardiol.org\/article\/desfechos-em-pacientes-com-fenomeno-de-no-reflow-coronario-e-a-relacao-entre-a-molecula-1-de-lesao-renal-e-o-fenomeno-de-no-reflow-coronario\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,19]]}},"alternative-id":["10.36660\/abc.20190656"],"URL":"https:\/\/doi.org\/10.36660\/abc.20190656","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}